ClinicalTrials.gov
public full text
Public Domain
A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies
HS-196 is near infrared red (NIR)-tethered HSP90 inhibitor for clinical imaging of selective tumor binding. HS-196 consists of a HSP90 inhibitor that binds competitively to the Hsp90 ATP binding domain connected by a linker to a contrast agent (near infrared (NIR) dye) that can be used for imaging. HS-196 can freely enter tumor cells to selectively bind Hsp90. Due to the the NIR dye, HS-196 accumulation in the malignant cells allows for specific visualization of tumors within the body.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors#889043
- Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies#825208
- Imaging of Solid Tumors Using FAP-2286#904033
- [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer#1087184
- Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer#916591
Record · ID 851066
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive